HomeInsightsEPS

Astrazeneca Pharma India Ltd EPS

Astrazeneca Pharma India Ltd EPS

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

EPS

₹ 51.49

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Astrazeneca Pharma India Ltd is ₹ 51.49 as of 22 Nov 24 .
  • The earning per share of Astrazeneca Pharma India Ltd changed from ₹ 8.06 to ₹ 16.37 over 10 quarters. This represents a CAGR of 32.77% .

Historical Earning per Share of Astrazeneca Pharma India Ltd

No data available

* All values are in

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

15,842 Cr

EPS

51.5

P/E Ratio (TTM) *

123.1

P/B Ratio (TTM) *

23.3

Day’s High *

6421.15

Day’s Low

6305.05

DTE *

0.0

ROE *

18.9

52 Week High

8139.85

52 Week Low

4050.15

ROCE *

23.9

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20246336.9
21 Nov 20246288.9
19 Nov 20246497.5
18 Nov 20246397.65
14 Nov 20246770.6
13 Nov 20247133.1
12 Nov 20247410.5
11 Nov 20247252.7
08 Nov 20247317.65
07 Nov 20247517

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

15,842

Asset Value

955

15.6 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Astrazeneca Pharma India Ltd5115,842
Sun Pharmaceuticals Industries Ltd464,31,352
Divis Laboratories Ltd691,59,265
Cipla Ltd571,20,033
Torrent Pharmaceuticals Ltd511,07,301
Mankind Pharma Ltd521,02,231

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca Pharma gains on plan to launch COPD drug

Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...

Read more

19 Nov 202412:11

News

AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr

Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...

Read more

14 Nov 202412:34

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 202416:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 202408:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 202412:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...

Read more

24 Sep 202414:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Astrazeneca Pharma India Ltd

What is the EPS of Astrazeneca Pharma India Ltd stock?

The Earnings Per Share (EPS) of Astrazeneca Pharma India Ltd is 51.49. An EPS is the amount of net income attributed to each share of a common stock.

How is Astrazeneca Pharma India Ltd EPS calculated?

The EPS of Astrazeneca Pharma India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Astrazeneca Pharma India Ltd report its EPS?

Astrazeneca Pharma India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Astrazeneca Pharma India Ltd EPS?

Factors that influence the EPS of Astrazeneca Pharma India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Astrazeneca Pharma India Ltd EPS growth indicate future performance?

Yes, consistent growth in Astrazeneca Pharma India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*